Phase II study of monthly pasireotide LAR (SOM230C) for recurrent or progressive meningioma

OBJECTIVE: A subset of meningiomas recur after surgery and radiation therapy, but no medical therapy for recurrent meningioma has proven effective. METHODS: Pasireotide LAR is a long-acting somatostatin analog that may inhibit meningioma growth. This was a phase II trial in patients with histologica...

Full description

Saved in:
Bibliographic Details
Published in:Neurology
Main Authors: Norden, Andrew D., Ligon, Keith L., Hammond, Samantha N., Muzikansky, Alona, Reardon, David A., Kaley, Thomas J., Batchelor, Tracy T., Plotkin, Scott R., Raizer, Jeffrey J., Wong, Eric T., Drappatz, Jan, Lesser, Glenn J., Haidar, Sam, Beroukhim, Rameen, Lee, Eudocia Q., Doherty, Lisa, Lafrankie, Debra, Gaffey, Sarah C., Gerard, Mary, Smith, Katrina H., McCluskey, Christine, Phuphanich, Surasak, Wen, Patrick Y.
Format: Artigo
Language:Inglês
Published: Lippincott Williams & Wilkins 2015
Subjects:
Article
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC4335993/
https://ncbi.nlm.nih.gov/pubmed/25527270
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1212/WNL.0000000000001153
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items